Jump to ContentJump to Main Navigation
Equity and AccessHealth Care Studies in India$
Users without a subscription are not able to see the full content.

Purendra Prasad, Amar Jesani, and Sujata Patel

Print publication date: 2018

Print ISBN-13: 9780199482160

Published to Oxford Scholarship Online: July 2019

DOI: 10.1093/oso/9780199482160.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 16 January 2021

Access to Pharmaceuticals

Access to Pharmaceuticals

Role of State, Industry, and Market

(p.154) 7 Access to Pharmaceuticals
Equity and Access

S. Srinivasan

Malini Aisola

Oxford University Press

Affordability, accessibility, availability, and rationality of medicines are a big challenge in India. Notwithstanding the tag of 'pharmacy of the developing world', the India story is one of poverty and poor access among plenty. The pharma market in India is riven by market failures due to asymmetries of various kinds: between patients, doctors, and pharmaceutical companies. Expecting the market to regulate itself will not work and proactive state intervention is necessary in pricing and provision of medicines and health care services to deal with the extraordinary crisis of public health in India.

Keywords:   Affordability, accessibility, availability and rationality of medicines, drug pricing policy, universal, free access to health care

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .